CINECA IRIS Institutional Research Information System

Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios

Saglio, Giuseppe
First
;
2017-01-01
2017
ANNALS OF HEMATOLOGY
96
8
1303
1313
link.springer.de/link/service/journals/00277/index.htm
Cardiovascular; Chronic myeloid leukemia; Dasatinib; Ischemic; Tyrosine kinase inhibitors; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Clinical Trials as Topic; Dasatinib; Female; Humans; Incidence; Ischemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Outcome Assessment (Health Care); Prostatic Neoplasms; Protein Kinase Inhibitors; Hematology
Saglio, Giuseppe*; le Coutre, Philipp; Cortes, Jorge; Mayer, Jiří; Rowlings, Philip; Mahon, François-Xavier; Kroog, Glenn; Gooden, Kyna; Subar, Milayn...espandi
03A-Articolo su Rivista
File in questo prodotto:
File Dimensione Formato  
paper5.docx

Accesso aperto

Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 175.72 kB
Formato Microsoft Word XML
Visualizza/Apri
175.72 kB Microsoft Word XML Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1701821
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 14
social impact